The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Women with polycystic ovary syndrome (PCOS) have reproductive and metabolic abnormalities that result in an increased risk of infertility, diabetes and cardiovascular disease. The large intestine contains a complex community of microorganisms (the gut microbiome) that is dysregulated in humans with obesity and type 2 diabetes. Using a letrozole-induced PCOS mouse model, we demonstrated significant diet-independent changes in the gut microbial community, suggesting that gut microbiome dysbiosis may also occur in PCOS women. Letrozole treatment was associated with a time-dependent shift in the gut microbiome and a substantial reduction in overall species and phylogenetic richness. Letrozole treatment also correlated with significant changes in the abundance of specific Bacteroidetes and Firmicutes previously implicated in other mouse models of metabolic disease in a time-dependent manner. Our results suggest that the hyperandrogenemia observed in PCOS may significantly alter the gut microbiome independently of diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig 1 Letrozole treatment of 4-week-old female mice resulted in both reproductive and metabolic hallmarks of PCOS. Five weeks of letrozole treatment resulted in increased serum testosterone (A), acyclicity (B), polycystic ovaries (C), increased body weight (D), increased fat mass (E), increased parametrial fat pad relative to body weight (F), and an impaired glucose tolerance test with elevated basal glucose levels and significant delays in glucose clearance after intraperitoneal injection previously published in [35] (G); n = 10 placebo (P) and letrozole (LET). * p<0.05 Student’s t-test. CL, corpus luteum.](https://figures.cochat.ai/paper-figures/0fc1bb278b3a48509ddc9f4ea332bc6f/the-gut-microbiome-is-altered-in-a-letrozole-induced-mouse-model-of-polycystic-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The negative correlation between testosterone and microbiota diversity in women with PCOS was also observed in a PCOS mouse model while the positive association between testosterone and Ruminococcus in healthy men was also observed in neonatally-androgenized rats.(12, 25, 31)”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“In particular, mice models have shown a correlation between the microbiota and hyperandrogenaemia in mice with polycystic ovary syndrome (PCOS).(11-13)t”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice
Caricilli, A. M., Picardi, P. K., de Abreu, L. L., Ueno, M., Prada, P. O., Ropelle, E. R., Hirabara, S. M., Castoldi, Â., Vieira, P., Camara, N. O. S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001212 · Cited by 282
RetractedQIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“Sequences were then aligned using PyNast [26] and a phylogenetic tree constructed using FastTree [31].”
MethodSelf-citationSearch and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885 · cited 1×
“Sequences were assigned to OTUs with an assumed 97% threshold of pairwise identity for bacterial species by comparison with the Greengenes reference database [29] using the RDP classifier [30].”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Furthermore, studies have shown that transplantation of the obese gut microbiome into germ-free mice results in an obese phenotype [11, 21, 22], indicating that dysregulation of the gut microbiome may play a causative role in the development of metabolic disorders [23].”
BackgroundUltra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839 · cited 1×
“16S ribosomal RNA genes were amplified by PCR using 16S primers (515F and 806R) that target the V4 hypervariable region [24].”
MethodHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227 · cited 1×
“UniFrac measures the similarity among microbial communities by calculating the shared phylogenetic diversity between pairs of microbial communities [34].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“Furthermore, studies have shown that transplantation of the obese gut microbiome into germ-free mice results in an obese phenotype [11, 21, 22], indicating that dysregulation of the gut microbiome may play a causative role in the development of metabolic disorders [23].”
BackgroundA metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Cited by
Items 101–200 of 205
Kusamoto, A., Harada, M., Azhary, J. M. K., Kunitomi, C., Nose, E., Koike, H., Xu, Z., Urata, Y., Kaku, T., Takahashi, N., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101051r · Cited by 19
Positive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome
Cardinale, V., Lepore, E., Basciani, S., Artale, S. A., Nordio, M., Bizzarri, M., & Unfer, V. (2022) · Nutrients · doi:10.3390/nu14153220 · Cited by 19
“In addition, previous evidence demonstrated the shifts of gut microbiota in mouse models of letrozole-induced PCOS compared with wildtype ones [52].”
ResultHo, B., Ryback, D., Benson, B., Mason, C. N., Torres, P. J., Quinn, R. A., Thackray, V. G., & Kelley, S. T. (2021) · mSystems · doi:10.1128/msystems.01149-20 · Cited by 21
“in the alpha diversity and composition of the gut microbiome (24, 25).”
BackgroundSelf-citationProbiotic supplement for the treatment of polycystic ovarian syndrome
Ramzan, H., Bukhari, D. A., Bibi, Z., Arifullah, Isha, I., Nawaz, A., & Rehman, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108785 · Cited by 20
Social Isolation and Breast Cancer
Hilakivi-Clarke, L. A., & Andrade, F. D. O. (2023) · Endocrinology · doi:10.1210/endocr/bqad126 · Cited by 23
Myricetin ameliorates polycystic ovary syndrome in mice by brown adipose tissue activation
Zheng, N., Wang, C., Li, Y., Fu, H., & Hu, T. (2024) · Reproduction · doi:10.1530/rep-24-0034 · Cited by 15
Sun, Z., Yu, S., Tian, Y., Han, B., Zhao, Y. M., Li, Y., Wang, Y., Sun, Y., & Shen, W. (2021) · Food & Function · doi:10.1039/d1fo03145g · Cited by 15
Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy
Sabeel, Z., & Zhao, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02456-x · Cited by 21
“Similarly, letrozole shifts the gut composition by enriching Firmicutes and reducing Bacteroidales [97, 98].”
Geng, Y., Liu, Z., Hu, R., Ma, W., Wu, X., Dong, H., Song, K., Xu, X., Huang, Y., Li, F., et al. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01236-9 · Cited by 16
“Wang et al. found IL-22-Fc administration in DIO mice noticeably reversed the decreased ratio of Bacteroidetes to Firmicutes that was found in obese models [22, 120].”
BackgroundInfluentialLiu, C., Gao, P., Liu, X., Kuang, M., Xu, H., Wu, Y., Liu, W., & Wang, S. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01087-0 · Cited by 15
“Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder affecting women of reproductive age, characterized by oligo-anovulation, hyperandrogenism, polycystic ovarian morphology, and metabolic dysregulation, including abdominal obesity and insulin resistance (IR) [183].”
Introductory Overview of Statistical Analysis of Microbiome Data
Xia, Y., Sun, J., & Chen, D. (2018) · ICSA book series in statistics · doi:10.1007/978-981-13-1534-3_3 · Cited by 16
LeBrun, E. S., Nighot, M., Viszwapriya, D., Kumar, A., Lo, C., Chain, P., & Ma, T. Y. (2020) · Life · doi:10.3390/life11010007 · Cited by 14
Parua, S., Hazra, A., Adhikary, K., Ganguly, K., Ahuja, D., Maiti, R., Mukhopadhyay, L. D., Dutta, S., Panda, P., Bhattacharya, K., et al. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100626 · Cited by 15
The emerging role of the gut microbiome in polycystic ovary syndrome
He, Y., Jin, X., Wang, H., Dai, H., Lu, X., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021) · F&S Reviews · doi:10.1016/j.xfnr.2021.03.003 · Cited by 16
Khobragade, N. H., Sheth, D. B., Patel, C. A., Beladiya, J., Patel, S. P., & Dalal, M. (2024) · Steroids · doi:10.1016/j.steroids.2024.109455 · Cited by 14
Gut microbiota and ovarian diseases: a new therapeutic perspective
Ju, S., Kang, Z., Yang, L., Xia, Y., Guo, Y. M., Li, S., Yan, H., Mao, Q., Wang, H. P., & Zhong, L. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01684-5 · Cited by 13
“Kelley et al. demonstrated the changes in gut microbiota at the phylum level, using a letrozole-induced PCOS mouse model [53].”
Lindheim, L., Manti, M., Fornes, R., Bashir, M., Czarnewski, P., Diaz, O. E., Seifert, M., Engstrand, L. G., Villablanca, E. J., Obermayer-Pietsch, B. M., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00266 · Cited by 13
“Decreased bacterial richness and community changes have also been reported in amousemodel of PCOS [15].”
BackgroundResultPieczyńska-Zając, J. M., Malinowska, A. M., Pruszyńska‐Oszmałek, E., Kolodziejski, P. A., Drzymała-Czyż, S., & Bajerska, J. (2024) · Nutrition · doi:10.1016/j.nut.2024.112450 · Cited by 10
Dai, G., Zhang, Y., Shen, C., Jiao, Y., Shen, W., Yu, F., Liu, R., Wang, D., Yuan, G., & Jia, J. (2025) · Phytotherapy Research · doi:10.1002/ptr.70043 · Cited by 11
Sau, L., Olmstead, C., Cui, L. J., Chen, A., Shah, R. S., Kelley, S. T., & Thackray, V. G. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa173 · Cited by 13
“As described previously [30], DNA was extracted from the fecal samples and amplified via polymerase chain reaction using primers 515F and 806R.”
MethodSelf-citationZhang, F., Tang, C., Wang, J., Lin, T., Ge, W., He, C., Yang, C., & Zuo, Z. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123723 · Cited by 10
Sharma, U., Sahu, A., Thakur, N., Choudhary, R. K., Shekhar, H., Haque, S., Tuli, H. S., Aubakirova, A. T., & Sharma, B. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05409-6 · Cited by 15
Yang, J., Wang, E., Jiang, M., Tan, Y., Yao, F., Sun, C., Pan, L., Gao, L., & Yao, J. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01193-3 · Cited by 11
“Previous studies have found that the relative abundance of Ruminococcaceae was higher in obese patients with PCOS and letrozole-induced PCOS rat models [37, 45, 46].”
ResultProbiotics ameliorates hypothalamic amenorrhea in a rat model of PCOS
Areloegbe, S. E. J., Obong, N. N., Badejogbin, O. C., Oniyide, A. A., Ajadi, I. O., Atuma, C. L., Ajadi, M. B., Adelekan, O. E., & Olaniyi, K. S. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01573-2 · Cited by 10
“Subsequent studies have reinforced this link, showing associations between gut microbiome changes and PCOS in animal models and human subjects (Kelley et al. 2016; Lindheim et al. 2017).”
Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies
Du, X., Su, H., Huang, Y., Liu, J., Li, Q., Yang, X., Tao, X., & Li, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1747766 · Cited by 12
Lee, Y. Z., Cheng, S.-H., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168706 · Cited by 11
Genetic and Environmental Factors in the Etiology of Polycystic Ovary Syndrome
Barber, T. M., & Franks, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00027-3 · Cited by 12
Shah, R. D. (2019) · Children · doi:10.3390/children6080089 · Cited by 9
“A Letrozole-induced mouse model of PCOS found lower diversity and increase in Bacteroides and Firmicutes species that were previous associated with mouse models of metabolic disease [68].”
BackgroundQi, S., Yu, H., Hu, W., Xia, D., Shi, Q., & Wang, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-15026-4 · Cited by 13
“Although many studies 14,36–38 confirmed that letrozole can increase body weight and lipid level in rats, according to our data, the effect of letrozole is far less than that directly driven by HFD, and fat accumulation is difficult to eliminate in a short time.”
Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female mice
Chen, A., Handzel, A. A., Sau, L., Cui, L. J., Kelley, S. T., & Thackray, V. G. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.443 · Cited by 10
“…changes in overall gut bacteria composition were detectable after 2 weeks of DHT, OVX or OVX + DHT treatment, which is sim - ilar to LET treatment, 32,33 indicating that elevated androgens and oestrogen insufficiency due to OVX appear to exert detectable ef - fects on gut microbes in a similar…”
BackgroundSelf-citationZhang, T., Gao, H., Fan, Y., Chen, S., Li, Y., Liu, R., Li, T., & Yin, C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121912 · Cited by 9
Methodology for microbiome data analysis: An overview
Creus-Martí, I., Moyá, A., & Gómez, F. J. S. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110157 · Cited by 10
The dynamic relationship of gut microbiota with sex hormones in systemic lupus erythematosus
Katrib, M., Haddad, R., Hamdan, Z., & Rida, M. A. (2023) · Reumatologia/Rheumatology · doi:10.5114/reum/163091 · Cited by 8
Maternal obesity and resistance to breast cancer treatments among offspring: Link to gut dysbiosis
Andrade, F. D. O., Verma, V., & Hilakivi-Clarke, L. A. (2022) · Cancer Reports · doi:10.1002/cnr2.1752 · Cited by 6
“inhibitor letrozole decreased the abundance of Bacteroidetes and increased SCFA producing Firmicutes, including Lachnospiraceae and Ruminococcaceae in a preclinical model.(106) In a human study, FMT”
BackgroundPanchal, D., Pandya, T., Kevlani, V., Shah, S., & Acharya, S. P. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01304-z · Cited by 8
Wei, Z., Chen, Z., Xiao, W., & Wu, G. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2239933 · Cited by 9
“A study found that androgen levels in the PCOS mouse model could drastically change the gut microbiota [44].”
An overview of the physiopathology and various treatment strategies for polycystic ovary syndrome
Rajabi, A., Babaie, S., Oskouei, B. S., Mehdizadeh, A., & Farshbaf‐Khalili, A. (2023) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000088 · Cited by 7
Corrie, L., Singh, H., Gulati, M., Vishwas, S., Chellappan, D. K., Gupta, G., Paiva‐Santos, A. C., Veiga, F., Alotaibi, F., Alam, A., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03029-3 · Cited by 6
RetractedKusamoto, A., Harada, M., Minemura, A., Matsumoto, A., Oka, K., Takahashi, M., Sakaguchi, N., Azhary, J. M. K., Koike, H., Xu, Z., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1365624 · Cited by 5
Wu, R., Mai, Z., Song, X., & Zhao, W. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1524521 · Cited by 5
Endometrial Receptivity in Patients with Polycystic Ovary Syndrome
Albu, A. I., & Albu, D. N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98624 · Cited by 5
Salivary microbiome differences in prepubertal children with and without adrenal androgen excess
Wise-Oringer, B. K., Burghard, A. C., Park, H., Auchus, R. J., Oberfield, S. E., & Uhlemann, A. (2021) · Pediatric Research · doi:10.1038/s41390-021-01661-w · Cited by 3
Metagenome-Assembled Genomes from Murine Fecal Microbiomes Dominated by Uncharacterized Bacteria
Rastegar, K., Kelley, S. T., & Thackray, V. G. (2023) · Microbiology Resource Announcements · doi:10.1128/mra.01162-22 · Cited by 4
Self-citationVilhais, G., Costa, D. A., Fontes-Sousa, M., Ribeiro, P. C., Martinho, F., de Sousa, C. B., dos Santos, C. R., Negreiros, I., Canastra, A., Borralho, P., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1360737 · Cited by 6
Chemically-induced histopathological progression in the polycystic ovary syndrome (PCOS)- A review
Javed, M., Suramya, S., Ahmad, S., & Raisuddin, S. (2025) · Toxicological Research · doi:10.1007/s43188-025-00296-x · Cited by 4
Animal models of polycystic ovary syndrome
Kulkarni, S., Dahake, D., Gupta, K., Rathod, K., Aswar, U. M., & Thareja, S. (2025) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2025.2551005 · Cited by 3
“Letrozole, an aromatase inhibitor currently in clinical practice, is commonly used as a reliable PCOS-inducing agent in various animal models (Kelley et al. 2016; Mamounas et al. 2019).”
Yin, L., Yang, W., Xie, Q., Xu, J., Lan, Y., & Wu, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1700612 · Cited by 4
Kuang, J., Luo, J., He, X., Yu, T., Zhou, Y., Zhang, X., Liu, Z., & Chen, T. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.107061 · Cited by 4
Host–microbiome interactions in breast cancer progression and treatment response
Bautista, J., Lara-Hernández, M. E., Cruz, M. H.-D. L., Andino-Araque, V., León-Rivera, M., & López‐Cortés, A. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1827694 · Cited by 4
“Microbial restructuring under endocrine suppression has been associated with increased adiposity, altered lipid metabolism, and heightened inflammatory tone, biological processes that may contribute to metabolic complications and endocrine resistance during long-term therapy (164, 165).”
Huang, X., Wu, L., Zhang, Y., Lai, X., & Sun, D. (2025) · Endocrine Connections · doi:10.1530/ec-25-0162 · Cited by 3
Femi-Olabisi, F. J., Ishola, A. A., Yusuf, B. O., Olanike, K. I., & Adesoji, P. A. (2024) · ChemistrySelect · doi:10.1002/slct.202304721 · Cited by 3
Veličković, N. A., Vratarić, M., Mićić, B., Teofilović, A., Radovanović, M., Ignjatović, S., Gašić, U., Djordjevic, A. D., Μacut, D., & Milutinović, D. V. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01103-9 · Cited by 2
“This result is in accordance with both human and PCOS animal model studies [14, 29].”
InfluentialBhati, P., Haloi, P., Munjal, K., & Chitme, H. R. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105844 · Cited by 2
An Insight into Experimental Animal Models for Polycystic Ovarian Syndrome and Associated Disorders
Patil, S. B., & Kulkarni, Y. A. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-02004-4 · Cited by 2
“Two studies carried out in 2016 and 2017 initially presented evidence indicating that alterations in the gut microbiota were correlated with PCOS in an animal model and PCOS-affected women [68].”
Liu, J., Yang, H., Xiao, Z.-Y., Xie, J.-H., Su, L., Yi-ting, L., Zheng, X., Hu, W.-H., Fu, S.-J., Li, C.-L., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1730714 · Cited by 3
“(Kelley et al., 2016) were increased, which may be closely related to the pathogenesis of PCOS.”
Li, Q., Wu, Y., Chen, L., & Wang, R. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00703-w · Cited by 2
Kong, F., Huang, P., Chen, J., & Ma, Y. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01562-3 · Cited by 5
Naseri, L., Akbaribazm, M., & Khazaei, M. (2024) · OBM Genetics · doi:10.21926/obm.genet.2403248 · Cited by 2
Henry, N. L., Kidwell, K., Kozar, S., Snyder, S., & Zick, S. M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0311044 · Cited by 3
Polycystic ovary syndrome – 80 years of research and new directions in the study (literature review)
Дамдинова, Damdinova, L., Лещенко, & Leshchenko, O. Y. (2016) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.12737/23421 · Cited by 3
Genetic basis of metabolism and inflammation in PCOS
Pang, Y., Zhao, Y., & Qiao, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00002-2 · Cited by 3
Ni, Z., Cheng, W., Ding, J., Yao, R., Zhang, D., Zhai, D., Zhou, L., & Yu, C. (2020) · Research Square · doi:10.21203/rs.3.rs-117891/v1 · Cited by 2
Toll-like Receptor 4 Contributes to PCOS-like Metabolic and Reproductive PathogenesisPreprint
Wiggins, K. D., Mundo, Z. D. D., Angulo, J. A. A., Naidu, N., Saba, A., Garcia, C., Nguyen, C. M., Ujagar, N. S., Torre, J.-J. D. L., Robles, G. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.16.682907 · Cited by 2
Self-citationFu, X., Peng, D., Yu, Y., Cao, M., Zheng, X., & Wu, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1698734 · Cited by 1
“In women with PCOS, the gut microbial profile exhibits a marked increase in the phylum Bacteroidetes; within this phylum, Bacteroides species attenuate short-chain fatty acid (SCFA) production, thereby fostering obesity and insulin resistance (Kelley et al., 2016).”
Gut microbiota, lipid metabolism, and PCOS: A Mendelian randomization and mediation analysis
Li, W., Gan, J., Jiao, J., Li, J., Xu, L., Li, D., Geng, Y., Shen, M., Liang, J., Lin, H., et al. (2026) · Medicine · doi:10.1097/md.0000000000047177 · Cited by 1
“[26] In the present study, Enterococcus , Bacteroides , and Parabacteroides were found to be positively associated with PCOS.”
Patel, J., Chaudhary, H., Parekh, B., & Joshi, R. G. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02081-2 · Cited by 2
“These changes align with patterns seen in metabolic and inflammatory disorders, implying a connection between gut dysbiosis and PCOS [49, 50].”
Gut microbiota and pattern recognition receptors in polycystic ovary syndrome
Yuan, J., Sun, S., Ibrahim, E. H., Din, M. A. U., Mao, F., & Du, S. (2026) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2026.104882 · Cited by 2
Gut microbiota in PCOS: key microbial changes, potential mechanisms and clinical applications
Shi, S., Ma, J., Jing, X., Jia, W., & Sun, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08352-2 · Cited by 2
“Moreover, it was further revealed that hyperandrogenemia could induce IR and metabolic abnormalities in PCOS by modifying the structure of the gut microbiota [102].”
Microbiota and its therapeutic implications in reproductive health and diseases
Singh, P., & Srivastava, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00003-3 · Cited by 5
Research Progress of Hyperandrogen in Polycystic Ovary Syndrome
谭, 金. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142475 · Cited by 1
A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice
Zhou, B., Guo, F., Long, Y., She, J., Ling, G., & Huang, H. (2024) · Journal of Visualized Experiments · doi:10.3791/66637 · Cited by 1
Cystic and hormonal changes in ovary of rabbit's hyperimmunized with Pseudomonas aeruginosa
Zabbon, A. A., Saeed, N. A.-H. A. H., & Ali, K. H. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100570
Ho, B., Ryback, D., Benson, B., Torres, P. J., Quinn, R. A., Thackray, V. G., & Kelley, S. T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.01.322701
Self-citationAiman, Z., Khanam, A., Maqsood, M., Ayyaz, M., Alia, M., & Kanwal, T. (2021) · Esculapio · doi:10.51273/esc20.2516412
Chestnut Polysaccharides Rescue Impaired Spermatogenesis by Adjusting Gut MicrobiotaPreprint
Sun, Z., Yu, S., Tian, Y., Han, B., Zhao, Y. M., Li, Y., Wang, Y., Sun, Y., & Shen, W. (2021) · Research Square · doi:10.21203/rs.3.rs-687294/v1
Семантика артикуляционных приёмов в хоровом дирижировании
Зиновьева, Л. П. (2010) · Мир науки, культуры, образования
Gut Microbiota and Eating Disorders on the Extremes of Aging
Miller, B. C., Mishra, S. P., Jain, S., Marotta, F., & Yadav, H. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_6 · Cited by 1
Microbiota e patologie endocrino-metaboliche
Antoniotti, V., Caputo, M., Antonioli, A., Spadaccini, D., Tini, S., Aimaretti, G., & Prodam, F. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01229-2
“Due studi del 2016 e 2017 hanno riportato per la prima volta l’evidenza che i cambiamenti nel microbioma intestinale erano associati alla PCOS in un modello murino e nell’uomo [23, 24].”
BackgroundDevelopmental origins and genetic basis of polycystic ovary syndrome
Barber, T., & Franks, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00009-5 · Cited by 1
A Tour-d’Horizon of microbiota therapeutics for metabolic disorders
Saifi, S., Swaminathan, A., Devi, P., Chattopadhyay, P., Gupta, S., Garg, A., Saxena, S., Parveen, S., & Pandey, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00006-9
Islam, R., & Saha, T. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815123975123010004
Perspectives of PCOS Pathophysiology: Exploring the Interplay between PCOS and the Gut Microbiota
Khade, K., Dadachanji, R., & Mukherjee, S. (2023) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34986
AL-Rekabi, S. A., & Noori, N. (2023) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.iq-31 · Cited by 2
Development of Research on the Etiology and Pathogenesis of Polycystic Ovary Syndrome
Wei, G., Wang, M., Yang, Y., & He, F. (2023) · Current Research in Medical Sciences · doi:10.56397/crms.2023.12.05
The relationship between polycystic ovary syndrome and intestinal flora
Zhao, Z. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3013199
“Experimental evidence has demonstrated that intestinal flora dysregulation can lead to hyperandrogenemia, insulin resistance, chronic inflammation, increased intestinal permeability and metabolic syndrome (such as diabetes and obesity), all of which are implicated in the progress of PCOS [7-11].”
BackgroundThe gut microbiota—as an endocrine organ
Kumar, P., & McEwan, I. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91141-2.00009-x
Features of the Gut Microbiota in Patients with Polycystic Ovary Syndrome
Дмитриевна, К. Е., Muravieva, V. V., Леонидовна, И. Е., Skorobogatiy, A. V., Zhigalova, K. N., Kozlova, A. A., Priputnevich, T. V., & Евгеньевна, Ч. Г. (2023) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn6442
Chestnut polysaccharides rescue impaired spermatogenesis by adjusting gut microbiotaPreprint
Sun, Z., Yu, S., Tian, Y., Han, B., Zhao, Y. M., Li, Y., Wang, Y., Sun, Y., & Shen, W. (2024) · doi:10.22541/au.170668093.35367017/v1
Yang, J., Wang, E., Jiang, M., Tan, Y., Yao, F., Sun, C., Pan, L., Gao, L., & Yao, J. (2023) · Figshare · doi:10.6084/m9.figshare.23298948
Introduction to gut microbiome and epigenetics
Oshinjo, A. M., Michael, O. S., Adedayo, L. D., Adetunji, C. O., Bamidele, O., Adetunji, J. B., Morakinyo, A., Akinwale, E. O., Ajayi, O. O., Awobajo, F. O., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91190-0.00009-6
Role of Gut Microbiota in Polycystic Ovary Syndrome
Dhiman, S., Gupta, A. A., & Garg, R. (2024) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2466
Assessing the role of drug interventions in the polycystic ovary syndrome model
Sirohi, E., Gupta, S., Tyagi, S., Ashique, S., Panigrahy, U. P., Jana, R., Singh, M. K., Mukherjee, S., & Haider, T. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04493-1
“Moreover, elevated abdominal adiposity and elevated fasting blood glucose (FBG) levels were observed in the letrozole-induced PCOS mouse model (Kelley et al. 2016).”
Gao, L., Zhang, Y., & Deng, Q. (2025) · Medicine · doi:10.1097/md.0000000000046099 · Cited by 1
Azouz, A. A., Ali, S. E., Abd-Elsalam, R. M., Emam, S. R., Galal, M. K., Elmosalamy, S. H., Alsherbiny, M. A., Hassan, B. B., Li, C. G., & Badawy, S. A. E. (2021) · Figshare · doi:10.6084/m9.figshare.14516483
Gut and Vaginal Microbiome Dysbiosis in PCOS
Kottahachchi, D., Subasinghe, C., & Bajaj, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010021
Characteristic Gut Microbiota in PCOS-IR Patients and Its Association with Endocrine Features
Liang, W., Yao, Y., Ren, X., Anran, X. U. E., Cai, M., Yu, J., Yu, C., Zhou, L., & Zhai, D. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s561487 · Cited by 4
“28 Studies have reported that the gut microbiota in a letrozole-induced PCOS-IR rat model showed a significant reduction in α-diversity and β-diversity restructuring, 29 which was validated in the DHEA/ HFD murine models and clinical cohorts.”
Llontop, M. E. M., Nauta, K. M., Gates, D. R., Wang, X., Cooper, J. F., & Burton, N. O. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.04.709558
“Since daf-2 ( e1368 ) animals are well-established to have abnormally long lifespans due to dietary restriction 8 , we hypothesize that pyruvate increases the rate of metabolism which results in decreased lifespan and restored development.”
Hormonal Imbalance and Gut Dysbiosis: Emerging Perspectives in Women’s Health
De, R., Chakrabortty, S., Das, J., Chaudhary, P., Patra, R., Sardar, K., Nath, R., Pal, R., Debnath, B., & Ashique, S. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11089-5 · Cited by 1
Ni, M., Wang, Q., Ye, T., Lei, H., Wang, Y., & Yuan, Y. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02164-0
“It is characterized by the proliferation of pro-inflammatory bacteria (e.g., certain Bacteroides species) and a marked reduction in metabolically protective genera (e.g., Akker-mansia, Alistipes, and Faecalibacterium, which are positively correlated with insulin sensitivity) [79–82].”
Park, H.-S., Corachán, A., Seok, J., Ali, F. L., Ghasroldasht, M. M., Akhtar, S., mohammed, H., Manier, C., Awartani, A., Ismail, N., et al. (2026) · Reproductive Medicine and Biology · doi:10.1002/rmb2.70082
Metadata
- Authors
- Kelley, S. T., Skarra, D. V., Rivera, A. J., & Thackray, V. G.
- Affiliations
- San Diego State University (US)
- University of California San Diego (US)
- Corresponding author
- Thackray, Varykina G.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-05
- Volume
- 11
- Issue
- 1
- Pages
- e0146509
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4701222
- OpenAlex
- W2225512866
- Cited by
- 205
- References
- 55
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 25 · 2023: 31 · 2022: 18 · 2021: 32 · 2020: 20 · 2019: 14 · 2018: 13 · 2017: 5 · 2016: 2
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Virginia (U54-HD28934)
- University of California, San Diego
- National Institute of General Medical Sciences (GM-068524, K12GM068524)
- National Institute of Child Health and Human Development (U54-HD28934, HD012303)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD012303, R01HD082567, F32HD074414, U54HD012303, U54HD028934, P50HD028934, R01HD067448, T32HD007203, U54-HD-28934)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- polycystic ovary syndrome, gut microbiota, dysbiosis, letrozole, hyperandrogenemia, Bacteroidetes, Firmicutes, species richness, mouse model, infertility, metabolic disorders
- MeSH terms
- Gastrointestinal Microbiome, Letrozole, Animals, Diet, Disease Models, Animal, Female, Nitriles, Polycystic Ovary Syndrome, Triazoles, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.